摘要
Glucose monitoring is an important component in diabetes treatment and management. The results of blood glucose monitoring are useful for determining the degree of glucose metabolic disturbance, evaluating therapeutic outcomes, and guiding adjustments of treatment regimens.1 Self-monitoring of blood glucose （SMBG） still remains the most common form of in-home blood glucose monitoring with the glycosylated hemoglobin （HbAlc） as the ＂gold standard＂ for understanding the patients＇ average glucose over the last 3 months. However, both HbA1 c and SMBG have certain limitations： HbAlc represents the average blood glucose level over the previous 2-3 months;
Glucose monitoring is an important component in diabetes treatment and management. The results of blood glucose monitoring are useful for determining the degree of glucose metabolic disturbance, evaluating therapeutic outcomes, and guiding adjustments of treatment regimens.1 Self-monitoring of blood glucose （SMBG） still remains the most common form of in-home blood glucose monitoring with the glycosylated hemoglobin （HbAlc） as the ＂gold standard＂ for understanding the patients＇ average glucose over the last 3 months. However, both HbA1 c and SMBG have certain limitations： HbAlc represents the average blood glucose level over the previous 2-3 months;
